Stock Movers: GoPro, Fervo, and Medtronic (Podcast)

GoPro surged up to 78% to $1.56 after signing a definitive merger agreement with Starman Optical to add an onshore optical transceiver business and support expansion into AI data center, government, defense, and aerospace markets. Fervo gained as much as 15% after a 396 MW power purchase agreement with Google for carbon-free geothermal energy from its Utah GeoCluster project expected online in 2028, giving visibility to ~1.1 GW through 2030. Medtronic shares rose on a fiscal Q1 beat and a boosted full-year organic revenue forecast, which RBC called a solid beat & raise.

Analysis

FRVO is the cleaner fundamental winner: the value is not the headline contract size, it is that a hyperscaler has effectively helped validate long-duration, firm, carbon-free baseload as financeable. That reduces the cost of capital for geothermal developers and should also lift sentiment for adjacent names that can sell 10+ year contracted electrons into data-center load growth; the second-order loser is any merchant-power strategy that assumed AI demand would be met only with gas peakers or incremental renewables.

GPRO is a very different trade: the market is starting to price it as a corporate shell with embedded optionality on optical/photonics rather than as a consumer hardware story. That can keep the float bid for a few sessions, but the real risk is that the equity becomes a funding currency for a small, execution-heavy business with integration and dilution risk; the move is likely overextended unless the merger terms are clearly accretive and non-dilutive.

MDT looks like a quality-defense confirmation rather than a re-rating event. The beat/raise matters because it suggests volume and pricing resilience in a sector where investors were braced for mix pressure; that supports peers with similar procedural exposure, but only if the next two quarters show sustained organic growth rather than one-time timing. The main falsifier across these names is simple: for FRVO, project slippage or power-price compression; for MDT, a guide-down on organic growth; for GPRO, any indication the transaction is more rescue financing than strategic expansion.

Key Decisions for Investors

• Long FRVO vs short a merchant power proxy basket (or ORA if liquidity is needed) for 3-6 months: thesis is that contracted AI/data-center power visibility deserves a higher multiple than spot-exposed generation; cut if the next financing round comes at a materially dilutive valuation or if project COD slips beyond 12 months.
• Buy GOOGL on pullbacks as a modest hedge to AI power scarcity: the operating impact is immaterial, but securing firm clean power lowers long-run data-center execution risk; trim if Google signals weaker capex discipline or delays in additional load commitments.
• Avoid chasing GPRO after the spike; if anything, consider a small short only after borrow normalizes and if the stock trades above implied deal value by >20% without financing detail. This is a trade on dilution/transaction disappointment, not on camera fundamentals.
• Add MDT on weakness over the next 1-2 weeks as a defensive compounder pair against higher-beta medtech names; risk/reward improves if the stock gives back the gap, and the thesis is invalidated by a second consecutive quarter of organic growth deceleration.